American CryoStem Corporation and Protein Genomics Form Autogenesis Corporation To Support Development Of Unique Stem Cell-Based Wound Products
Published: Nov 14, 2013
EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the formation of Autogenesis Corporation ("Autogenesis") as part of its collaborative agreement to develop wound healing products and other cellular therapies with privately-held Protein Genomics (PGen).
Help employers find you! Check out all the jobs and post your resume.